Digital Slide Imaging Evaluated for Cervicovaginal Cytology
|
By LabMedica International staff writers Posted on 26 Jun 2013 |

Image: BioImagene digital scanner (Photo courtesy of Ventana Medical Systems).
Digital imaging is the creation, storage, and transmission of an image file using a computer and is considered by many to be the future of anatomic pathology.
Whole slide imaging has been successfully used in surgical pathology, but its usefulness and clinical application have been limited in cytology for several reasons, including lack of availability of z-axis depth focusing and large file size.
Cytopathologists at The Methodist Hospital (Houston, TX, USA) investigated the accuracy and efficiency of whole slide imaging, as compared with traditional glass slides, for use in cervicovaginal diagnostic cytology. Eleven cervicovaginal cytology cases were evaluated by four cytotechnologists and three cytopathologists in a blinded study. Digitally scanned images were reviewed first, and different magnification scans were presented as separate cases in a random order. Corresponding glass slides were also reviewed and for each case, the diagnoses and total time to reach each diagnosis were recorded.
The specimens were prepared using both ThinPrep (BD Diagnostics TriPath; Burlington, NC, USA) and SurePath (Hologic Inc.; Marlborough, MA, USA). All the cases were scanned using the BioImagene iScan Coreo Au 3.0 scanner (Ventana Medical Systems Inc.; Sunnyvale, CA, USA). Diagnostic accuracy was higher and average time per case was lower with glass slides as compared with all digital images. Accuracy of interpretation of the digital images was best achieved with ×40 magnification, and z-stack digital images scanned at ×40 magnification improved the accuracy of diagnosis in one case of adenocarcinoma of the endometrium.
The authors concluded that whole slide imaging is a viable option for the purposes of teaching and consultations, and as a means of archiving cases. However, considering the large file size and total time to reach diagnosis on digital images, they consider whole slide imaging may not yet be ready as a daily screening tool in cervicovaginal diagnostic cytology. The study was published in the May 2013 edition of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
The Methodist Hospital
BD Diagnostics
Ventana Medical Systems
Whole slide imaging has been successfully used in surgical pathology, but its usefulness and clinical application have been limited in cytology for several reasons, including lack of availability of z-axis depth focusing and large file size.
Cytopathologists at The Methodist Hospital (Houston, TX, USA) investigated the accuracy and efficiency of whole slide imaging, as compared with traditional glass slides, for use in cervicovaginal diagnostic cytology. Eleven cervicovaginal cytology cases were evaluated by four cytotechnologists and three cytopathologists in a blinded study. Digitally scanned images were reviewed first, and different magnification scans were presented as separate cases in a random order. Corresponding glass slides were also reviewed and for each case, the diagnoses and total time to reach each diagnosis were recorded.
The specimens were prepared using both ThinPrep (BD Diagnostics TriPath; Burlington, NC, USA) and SurePath (Hologic Inc.; Marlborough, MA, USA). All the cases were scanned using the BioImagene iScan Coreo Au 3.0 scanner (Ventana Medical Systems Inc.; Sunnyvale, CA, USA). Diagnostic accuracy was higher and average time per case was lower with glass slides as compared with all digital images. Accuracy of interpretation of the digital images was best achieved with ×40 magnification, and z-stack digital images scanned at ×40 magnification improved the accuracy of diagnosis in one case of adenocarcinoma of the endometrium.
The authors concluded that whole slide imaging is a viable option for the purposes of teaching and consultations, and as a means of archiving cases. However, considering the large file size and total time to reach diagnosis on digital images, they consider whole slide imaging may not yet be ready as a daily screening tool in cervicovaginal diagnostic cytology. The study was published in the May 2013 edition of the journal Archives of Pathology & Laboratory Medicine.
Related Links:
The Methodist Hospital
BD Diagnostics
Ventana Medical Systems
Latest Pathology News
- Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis
- AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification
- Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer
- AI Pathology Tool Predicts DNA Repair Deficiency in High-Grade Serous Ovarian Cancer
- AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps
- AI Pre-Screening Helps Identify Lung Cancer Cases for Additional Biomarker Testing
- AI Pathology Platform Targets Workflow Delays and Molecular Test Failures
- Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis
- Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings
- AI Histopathology Tool Distinguishes Ewing Sarcoma for Diagnosis
- Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
- Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
- Multimodal AI Supports Prostate Cancer Risk Assessment Across Diverse Cohorts
- New AI Model Maps Where Glioblastoma Could Return After Surgery
- Simple Test Could Reduce the Need for Invasive Uterine Cancer Checks
- Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival
Channels
Clinical Chemistry
view channel
Blood Proteins Linked to Mortality Risk and Biological Aging Across Organ Systems
Older adults of the same chronological age can differ markedly in health, chronic disease burden, and resilience. Biological age aims to capture these differences by reflecting how rapidly the body and... Read more
Two-Step Blood Test Improves Specificity for Alzheimer’s Diagnosis
Early Alzheimer’s disease can be difficult to identify before more severe cognitive symptoms emerge. Blood tests measuring phosphorylated tau protein p-tau217 may help detect disease-related changes, but... Read moreMolecular Diagnostics
view channel
Liquid Biopsy Measures Tumor Burden and Identifies Small Cell Lung Cancer Subtypes
Small cell lung cancer (SCLC) accounts for roughly 15% of lung cancer cases and is characterized by rapid growth, early spread, and poor survival outcomes. Although scientists have identified molecular... Read more
Rapid Lab-Free UTI Test Enters First Use in Care Home Setting
Urinary tract infections (UTIs) frequently lead to hospital admission and antibiotic use among older residents of UK care homes. Diagnosis can be challenging when classic urinary symptoms are absent, particularly... Read moreHematology
view channel
New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL
Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read moreImmunology
view channel
Immune and Inflammatory Markers May Help Assess CAR T-Cell Complication Risk
Cytokine release syndrome (CRS) can occur after chimeric antigen receptor (CAR) T-cell therapy in patients with autoimmune disease. Identifying which patients are more likely to develop this complication... Read more
COVID-19 and Flu Combo Test Launches With FDA Clearance
Overlapping symptoms of COVID-19 and influenza can create diagnostic uncertainty, particularly in urgent and point-of-care settings. Rapid differentiation from a single specimen can streamline triage and... Read moreMicrobiology
view channel
Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea
Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more
Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read moreTechnology
view channel
Microfluidic Assay Predicts Treatment Response in Pediatric Leukemia
Acute lymphoblastic leukemia (ALL) is a rapidly developing blood cancer that can disrupt production of mature infection-fighting white blood cells within months. More than 120,000 people in the U.... Read more
AI Models Use Routine Blood Tests and Health Records to Predict Cancer Risk
Cancer screening programs cover only certain cancers and often rely on broad eligibility criteria, limiting individualized risk assessment across multiple cancer types. Routine health data, including blood... Read moreIndustry
view channel
CE-Marked IVD Sequencing Platform Launches Across Ten EU Countries
Clinical laboratories using sequencing in regulated diagnostic workflows need systems that support clearly defined processes and documentation. In Europe, meeting applicable EU IVDR requirements also means... Read more







